Generic imatinib approved in the US for CML: What does it mean for GIST patients?

[alert style="warning"]Note: The content of this article is current to the time of its posting on February 10, 2016. Please continue to check our site for the latest information on generics.[/alert] LRG Research Program to [...]

By | 2017-04-10T13:43:48+00:00 February 10th, 2016|Drug Treatment, Generics, Gleevec, News, Newsletter|

The heart of the matter: Cardiac health for GIST patients

The heart is at the center of the cardiovascular system, the main function of which is to pump blood throughout the body, providing tissue and organs with the oxygen and nutrients they need. To ensure [...]

By | 2016-03-21T14:39:38+00:00 February 10th, 2016|GIST Education, Newsletter, Side Effects|

Society for Integrative Oncology holds 12th annual conference in Boston

The Society for Integrative Oncology (SIO) was developed to advance evidence based, comprehensive, integrative healthcare to improve the lives of people affected by cancer. The 12th Annual SIO Conference was held in Boston in November, [...]

By | 2016-03-14T12:24:23+00:00 December 16th, 2015|Advocacy, Complementary Medicine, Newsletter|

Immunotherapy: Game Changing Cancer Treatments

Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News and [...]

By | 2016-03-14T12:28:04+00:00 October 15th, 2015|Drug Treatment, News, Research|

Potential treatment for imatinib-resistant GIST explored

Dr. Ron DeMatteo GIST specialist surgeon Dr. Ron DeMatteo, along with colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC), has published a new paper in the April issue of Cancer Research with potentially important [...]

By | 2016-03-14T12:32:59+00:00 June 16th, 2015|Drug Treatment, News, Research|

Side Effects of Targeted Treatments

The side effects of traditional chemotherapy treatments are often apparent, with images of bald patients with pain-etched faces captured in photographs. For targeted therapies such as those for GIST patients and other cancers that are [...]

By | 2016-04-04T15:49:01+00:00 April 27th, 2015|News, Side Effects, Survival Strategies|

Fatigue reduction: Moving towards a better future

As one of the most common side-effects of Gleevec, Sutent and Stivarga, fatigue is a condition that many GIST survivors are intimately acquainted with. The National Comprehensive Cancer Network defines cancer-related fatigue as “a distressing, [...]

By | 2016-03-14T14:30:30+00:00 April 7th, 2015|News, Side Effects|

Recent Posts

Upcoming Events

  1. Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM